That number confirmed something I've believed for a while: we built the chain to protect the product, not to reassure the ...

Mineralocorticoid receptor antagonist (MRA) Kerendia (finerenone) – one of Bayer's top growth prospects – is already approved ...

Generating good-quality patient experience data (PED) is becoming increasingly important for medicine development, and ...

Six months after Paul Chaplin said he was stepping down as chief executive of Bavarian Nordic, the Danish biopharma has named ...

Around 1,000 patients in England with a form of incurable breast cancer will be able to get access to AstraZeneca and Daiichi ...

Novo has added Anthropic's Claude to its drug discovery toolkit, shortly after the tech firm revealed a new AI workbench for ...

Chinese tech giant ByteDance – best known as the parent of social media app TikTok – has completed a $290 million financing ...

Curium's radioligand therapy Bexlutry has been approved in the US as a generic – or 'radioligand equivalent' (RLE) – of ...

GSK reported good clinical trial results with two of its lung cancer therapies – Jideytro and risvutatug rezetecan (ris-rez) ...

The FDA has published the design of its expedited Investigational New Drug (IND) pilot, part of a plan to restore US competitiveness in clinical research, and will now accept applications to take part ...

Amgen's fast-growing cancer immunotherapy Imdelltra could move into the first-line setting in small cell lung cancer (SCLC), ...

The Danish Group stated that the new corporate culture – dubbed 'The Novo Way' – centres around four Cs; namely, customer ...